Scientific Article
previous document  unige:106608  next document
add to browser collection
Title

Cerebrospinal fluid cortisol and clinical disease progression in MCI and dementia of Alzheimer's type

Authors
Wolfsgruber, Steffen
Heuser, Isabella
Peters, Oliver
Hüll, Michael
Schröder, Johannes
Möller, Hans-Jürgen
Lewczuk, Piotr
show hidden authors show all authors [1 - 18]
Published in Neurobiology of Aging. 2015, vol. 36, no. 2, p. 601-607
Abstract Increased peripheral and central nervous system cortisol levels have been reported in Alzheimer's disease (AD) and may reflect dysfunction of cerebral components of the hypothalamic-pituitary-adrenal (HPA) axis. However, brain exposure to high cortisol concentrations may also accelerate disease progression and cognitive decline. The objectives of this study were to investigate whether HPA-axis dysregulation occurs at early clinical stages of AD and whether plasma and CSF cortisol levels are associated with clinical disease progression. Morning plasma and CSF cortisol concentrations were obtained from the subjects with AD dementia, mild cognitive impairment of AD type (MCI-AD), MCI of other type (MCI-O), and controls with normal cognition included in a multicenter study from the German Dementia Competence Network. A clinical and neuropsychological follow-up was performed in a subgroup of participants with MCI-AD, MCI-O, and AD dementia. CSF cortisol concentrations were increased in the subjects with AD dementia or MCI-AD compared with subjects with MCI-O or normal cognition. After controlling for possible confounders including CSF measures of amyloid beta1-42 and total tau, higher baseline CSF cortisol levels were associated with faster clinical worsening and cognitive decline in MCI-AD. The findings suggest that HPA-axis dysregulation occurs at the MCI stage of AD and may accelerate disease progression and cognitive decline.
Keywords AgedAlzheimer Disease/blood/cerebrospinal fluid/diagnosis/physiopathologyAmyloid beta-Peptides/cerebrospinal fluidBiomarkers/blood/cerebrospinal fluidCognitive Dysfunction/blood/cerebrospinal fluid/diagnosis/physiopathologyCross-Sectional StudiesDisease ProgressionFemaleFollow-Up StudiesHumansHydrocortisone/blood/cerebrospinal fluidHypothalamo-Hypophyseal System/physiopathologyLongitudinal StudiesMaleMiddle AgedPeptide Fragments/cerebrospinal fluidPituitary-Adrenal System/physiopathologytau Proteins/cerebrospinal fluid
Identifiers
PMID: 25435336
Full text
Article (Published version) (349 Kb) - document accessible for UNIGE members only Limited access to UNIGE
Research group Neuropsychiatrie et Biomarqueurs de la maladie d'Alzheimer (991)
Citation
(ISO format)
POPP, Julius et al. Cerebrospinal fluid cortisol and clinical disease progression in MCI and dementia of Alzheimer's type. In: Neurobiology of Aging, 2015, vol. 36, n° 2, p. 601-607. https://archive-ouverte.unige.ch/unige:106608

10 hits

0 download

Update

Deposited on : 2018-07-24

Export document
Format :
Citation style :